Co-reporter:Kilian K. Kuhn, Timo Littmann, Stefanie Dukorn, Miho Tanaka, Max Keller, Takeaki Ozawa, Günther Bernhardt, and Armin Buschauer
ACS Omega July 2017? Volume 2(Issue 7) pp:3616-3616
Publication Date(Web):July 14, 2017
DOI:10.1021/acsomega.7b00451
The cross-linked pentapeptides (2R,7R)-diaminooctanedioyl-bis(Tyr-Arg-Leu-Arg-Tyr-amide) ((2R,7R)-BVD-74D, (2R,7R)-1) and octanedioyl-bis(Tyr-Arg-Leu-Arg-Tyr-amide) (2) as well as the pentapeptide Ac-Tyr-Arg-Leu-Arg-Tyr-amide (3) were previously described as neuropeptide Y Y4 receptor (Y4R) partial agonists. Here, we report on a series of analogues of (2R,7R)-1 and 2 in which Arg2, Leu3, or Arg4 were replaced by the respective aza-amino acids. The replacement of Arg2 in 3 with a carbamoylated arginine building block and the extension of the N-terminus by an additional arginine led to the high-affinity hexapeptide Ac-Arg-Tyr-Nω-[(4-aminobutyl)aminocarbonyl]Arg-Leu-Arg-Tyr-amide (35), which was used as a precursor for a d-amino acid scan. The target compounds were investigated for Y4R functional activity in assays with complementary readouts: aequorin Ca2+ and β-arrestin 1 or β-arrestin 2 assays. In contrast to the parent compounds, which are Y4R agonists, several ligands were able to suppress the effect elicited by the endogenous ligand pancreatic polypeptide and therefore represent a novel class of peptide Y4R antagonists.Topics: Amino acids; Biological and Medicinal chemistry; Peptides and Proteins; Proteins; Structure-activity relationship; Structure-activity relationship;
Co-reporter:Kilian K. Kuhn; Thomas Ertl; Stefanie Dukorn; Max Keller; Günther Bernhardt; Oliver Reiser
Journal of Medicinal Chemistry 2016 Volume 59(Issue 13) pp:6045-6058
Publication Date(Web):May 25, 2016
DOI:10.1021/acs.jmedchem.6b00309
The diastereomeric mixture of d/l-2,7-diaminooctanedioyl-bis(YRLRY-NH2) (BVD-74D, 2) was described in the literature as a high affinity Y4 receptor agonist. Here we report on the synthesis and pharmacological characterization of the pure diastereomers (2R,7R)- and (2S,7S)-2 and a series of homo- and heterodimeric analogues in which octanedioic acid was used as an achiral linker. To investigate the role of the Arg residues, one or two arginines were replaced by Ala. Moreover, Nω-(6-aminohexylaminocarbonyl)Arg was introduced as an arginine replacement (17). (2R,7R)-2 was superior to (2S,7S)-2 in binding and functional cellular assays and equipotent with 17. [3H]Propionylation of one amino group in the linker of (2R,7R)-2 or at the primary amino group in 17 resulted in high affinity Y4R radioligands ([3H]-(2R,7R)-10, [3H]18) with subnanomolar Kd values.
Co-reporter:Roland Geyer; Uwe Nordemann; Andrea Strasser; Hans-Joachim Wittmann
Journal of Medicinal Chemistry 2016 Volume 59(Issue 7) pp:3452-3470
Publication Date(Web):March 23, 2016
DOI:10.1021/acs.jmedchem.6b00120
2-Cyano-1-[4-(1H-imidazol-4-yl)butyl]-3-[2-(phenylsulfanyl)ethyl]guanidine (UR-PI376, 1) is a potent and selective agonist of the human histamine H4 receptor (hH4R). To gain information on the active conformation, we synthesized analogues of 1 with a cyclopentane-1,3-diyl linker. Affinities and functional activities were determined at recombinant hHxR (x: 1–4) subtypes on Sf9 cell membranes (radioligand binding, [35S]GTPγS, or GTPase assays) and in part in luciferase assays on human or mouse H4R (HEK-293 cells). The most potent H4R agonists among 14 racemates were separated by chiral HPLC, yielding eight enantiomerically pure compounds. Configurations were assigned based on X-ray structures of intermediates and a stereocontrolled synthetic pathway. (+)-2-Cyano-1-{[trans-(1S,3S)-3-(1H-imidazol-4-yl)cyclopentyl]methyl}-3-[2-(phenylsulfanyl)ethyl]guanidine ((1S,3S)-UR-RG98, 39a) was the most potent H4R agonist in this series (EC50 11 nM; H4R vs H3R, >100-fold selectivity; H1R, H2R, negligible activities), whereas the optical antipode proved to be an H4R antagonist ([35S]GTPγS assay). MD simulations confirmed differential stabilization of the active and inactive H4R state by the enantiomers.
Co-reporter:Martin Rothenhöfer, Marco Grundmann, Günther Bernhardt, Frank-Michael Matysik, Armin Buschauer
Journal of Chromatography B 2015 Volume 988() pp:106-115
Publication Date(Web):15 April 2015
DOI:10.1016/j.jchromb.2015.02.027
•A HPAEC-PAD method was developed to determine hyaluronan (HA) oligosaccharides.•Sensitive analysis of oligosaccharides comprising 2–25 disaccharides is enabled.•HPAEC-PAD plus CZE–ESI-TOF-MS revealed formation of odd-numbered oligosaccharides.•The method closes a gap in the analytical toolbox for hyaluronan oligosaccharides.•Combined methods allow studies on the biological role of HA and hyaluronidases.High performance anion exchange chromatography (HPAEC) with pulsed amperometric detection (PAD) was optimized for the analysis of oligosaccharides derived from the extracellular matrix component hyaluronan. Using this sensitive approach, the separation of oligosaccharides consisting of two (molecular weight ca. 0.8 kDa) up to 25–30 (molecular weight: ca. 9.5–11.4 kDa) disaccharide moieties was possible. Standard oligosaccharides (comprising 2–4 repetitive disaccharides) were detectable at very low amounts of 0.2–0.3 pmol (20–30 nM). Including 10 min of column equilibration, a complex mixture of low molecular weight hyaluronan can be analyzed within 40 min. The HPAEC method was successfully applied to the study of the size-dependency of both the action of bovine testicular hyaluronidase (BTH) and the precipitation of hyaluronan by cetyltrimethylammonium bromide (CTAB), a physicochemical reaction often used for the determination of hyaluronan and hyaluronidase activity.
Co-reporter:Roland Geyer, Patrick Igel, Melanie Kaske, Sigurd Elz and Armin Buschauer
MedChemComm 2014 vol. 5(Issue 1) pp:72-81
Publication Date(Web):07 Nov 2013
DOI:10.1039/C3MD00245D
In the search for potential bioisosteres of the 4-imidazolyl ring in acylguanidines (e.g. UR-AK24), known to possess affinity to several histamine receptor subtypes (HxR, x = 1–4), and cyanoguanidine-type H4R agonists (e.g. UR-PI376), the contribution of various heterocycles to agonism, antagonism and HR subtype selectivity was studied (recombinant human H1,2,3,4Rs, isolated guinea pig organs (H1R, H2R)). While minor structural modifications of UR-PI376 analogues were not tolerated regarding H4R agonism, in the case of the acylguanidines, a 1,2,4-triazole ring shifted the selectivity toward the H2R.
Co-reporter:Stefanie Bauer;Dr. Cristian Ochoa-Puentes;Qiu Sun;Manuel Bause;Dr. Günther Bernhardt;Dr. Burkhard König;Dr. Armin Buschauer
ChemMedChem 2013 Volume 8( Issue 11) pp:1773-1778
Publication Date(Web):
DOI:10.1002/cmdc.201300319